Valmir S.
About Valmir S.
Valmir S. is a Clinical Operations Manager at BeiGene in New Zealand, with extensive experience in clinical research and operations management across various companies in New Zealand, Australia, and Brazil.
Company
Valmir S. is currently employed at BeiGene as a Clinical Operations Manager in New Zealand. BeiGene is a biotechnology company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Title
Valmir S. holds the title of Clinical Operations Manager. His role involves overseeing clinical trials, managing study budgets, and ensuring compliance with regulatory processes. He is responsible for the successful execution of clinical studies in New Zealand, contributing to the company's mission of expanding access to life-saving treatments.
Professional Background
Valmir S. has extensive experience in clinical research and operations, having held various roles in different companies since 2004. He began his career as a Clinical Research Trainee at Novartis and worked his way up to senior positions such as Senior Clinical Research Associate and Clinical Team Manager. He has worked at Quintiles, ICON plc, PRA Health Sciences, MSD, and now BeiGene. His expertise spans multiple regions, including Brazil, Australia, and New Zealand.
Education and Expertise
Valmir S. studied Pharmacy and Biochemistry at Universidade de São Paulo, earning a Doctor of Pharmacy degree. He also completed a Technical degree in Business Administration and Management at ETE Camargo Aranha. His educational background has provided him with a comprehensive understanding of both clinical research methodologies and business management principles.
Clinical Operations Achievements
Valmir S. has spearheaded multiple initiatives throughout his career. Highlights include authoring Standard Operating Procedures for New Zealand Ethics and Regulatory processes and leading Phase 1 oncology trials. He has also delivered training sessions to Clinical Research Associates and investigators, contributed to informed consent processes, and successfully managed study budgets. His leadership has been recognized through four routine audits without any critical findings.